ANXA5 and acute myeloid leukemia: In order to determine the efficacy of T315 on primary AML cell viability, freshly isolated AML cells were treated with T315 (ranging from 0, 1, 2, 4 and 8 μmol/L) and the cell viability was evaluated by annexin-V/PI staining analysis.